Skip to main navigation Skip to search Skip to main content

Assessing the feasibility and impact of clinical trial trustworthiness checks via an application to Cochrane Reviews: Stage 2 of the INSPECT-SR project

  • Jack Wilkinson
  • , Calvin Heal*
  • , Georgios A. Antoniou
  • , Ella Flemyng
  • , Love Ahnström
  • , Alessandra Alteri
  • , Alison Avenell
  • , Timothy Hugh Barker
  • , David N. Borg
  • , Nicholas J. L. Brown
  • , Rob Buhmann
  • , Jose A. Calvache
  • , Rickard Carlsson
  • , Lesley-Anne Carter
  • , Aidan G. Cashin
  • , Sarah Cotterill
  • , Kenneth Färnqvist
  • , Michael C. Ferraro
  • , Steph Grohmann
  • , Lyle C. Gurrin
  • Jill A. Hayden, Kylie E. Hunter, Natalie Hyltse, Lukas Jung, Ashma Krishan, Silvy Laporte, Toby J. Lasserson, David R. T. Laursen, Sarah Lensen, Wentao Li, Tianjing Li, Jianping Liu, Clara Locher, Zewen Lu, Andreas Lundh, Antonia Marsden, Gideon Meyerowitz-Katz, Ben W. Mol, Zachary Munn, Florian Naudet, David Nunan, Neil E. O'Connell, Natasha Olsson, Lisa Parker, Eleftheria Patetsini, Barbara Redman, Sarah Rhodes, Rachel Richardson, Martin Ringsten, Ewelina Rogozińska, Anna Lene Seidler, Kyle Sheldrick, Katie Stocking, Emma Sydenham, Hugh Thomas, Sofia Tsokani, Constant Vinatier, Colby J. Vorland, Rui Wang, Bassel H. Al Wattar, Florencia Weber, Stephanie Weibel, Madelon van Wely, Chang Xu, Lisa Bero, Jamie J. Kirkham
*Corresponding author for this work
  • University of Manchester
  • Manchester University NHS Foundation Trust
  • Cochrane Central Executive
  • Karolinska Institutet
  • IRCCS San Raffaele Scientific Institute
  • University of Aberdeen
  • University of Adelaide
  • Australian Sports Commission
  • Queensland University of Technology
  • Linnaeus University
  • University of the Sunshine Coast
  • Erasmus University Rotterdam
  • Universidad del Cauca
  • Neuroscience Research Australia
  • University of New South Wales
  • University of Melbourne
  • Dalhousie University
  • The University of Sydney
  • CHU de Saint-Étienne
  • University of Southern Denmark
  • University of Colorado Anschutz Medical Campus
  • Beijing University of Chinese Medicine
  • Institut de Recherche en Santé, Environnement et Travail
  • University of Copenhagen
  • University of Wollongong
  • University of Oxford
  • Brunel University London
  • University of York
  • New York University
  • Lund University
  • Medical Research Council
  • University of Rostock
  • partner site Greifswald/Rostock
  • Cochrane Database of Systematic Reviews
  • The Lancet
  • Aristotle University of Thessaloniki
  • Indiana University Bloomington
  • Anglia Ruskin University
  • University of Würzburg
  • Amsterdam UMC - University of Amsterdam
  • Naval Medical University

Research output: Contribution to journalArticleAcademicpeer-review

27 Downloads (Pure)

Abstract

Background and Objectives: The aim of the INveStigating ProblEmatic Clinical Trials in Systematic Reviews (INSPECT-SR) project is to develop a tool to identify problematic RCTs in systematic reviews. In stage 1 of the project, a list of potential trustworthiness checks was created. The checks on this list must be evaluated to determine which should be included in the INSPECT-SR tool. Methods: We attempted to apply 72 trustworthiness checks to randomized controlled trials (RCTs) in 50 Cochrane reviews. For each, we recorded whether the check was passed, failed, or possibly failed or whether it was not feasible to complete the check. Following application of the checks, we recorded whether we had concerns about the authenticity of each RCT. We repeated each meta-analysis after removing RCTs flagged by each check and again after removing RCTs where we had concerns about authenticity to estimate the impact of trustworthiness assessment. Trustworthiness assessments were compared to Risk of Bias and Grading of Recommendations Assessment, Development and Evaluation (GRADE) assessments in the reviews. Results: Ninety-five RCTs were assessed. Following application of the checks, assessors had some or serious concerns about the authenticity of 25% and 6% of the RCTs, respectively. Removing RCTs with either some or serious concerns resulted in 22% of meta-analyses having no remaining RCTs. However, many checks proved difficult to understand or implement, which may have led to unwarranted skepticism in some instances. Furthermore, we restricted assessment to meta-analyses with no more than five RCTs (54% contained only 1 RCT), which will distort the impact on results. No relationship was identified between trustworthiness assessment and Risk of Bias or GRADE. Conclusion: This study supports the case for routine trustworthiness assessment in systematic reviews, as problematic studies do not appear to be flagged by Risk of Bias assessment. The study produced evidence on the feasibility and impact of trustworthiness checks. These results will be used, in conjunction with those from a subsequent Delphi process, to determine which checks should be included in the INSPECT-SR tool. Plain Language Summary: Systematic reviews collate evidence from randomized controlled trials (RCTs) to find out whether health interventions are safe and effective. However, it is now recognized that the findings of some RCTs are not genuine, and some of these studies appear to have been fabricated. Various checks for these “problematic” RCTs have been proposed, but it is necessary to evaluate these checks to find out which are useful and which are feasible. We applied a comprehensive list of “trustworthiness checks” to 95 RCTs in 50 systematic reviews to learn more about them and to see how often performing the checks would lead us to classify RCTs as being potentially inauthentic. We found that applying the checks led to concerns about the authenticity of around 1 in three RCTs. However, we found that many of the checks were difficult to perform and could have been misinterpreted. This might have led us to be overly skeptical in some cases. The findings from this study will be used, alongside other evidence, to decide which of these checks should be performed routinely to try to identify problematic RCTs, to stop them from being mistaken for genuine studies and potentially being used to inform health care decisions.
Original languageEnglish
Article number111824
JournalJ. Clin. Epidemiol.
Volume184
DOIs
Publication statusPublished - 1 Aug 2025

Keywords

  • Critical appraisal
  • Evidence synthesis
  • Fabrication
  • Forensic analysis
  • Fraud
  • Misconduct
  • Randomized controlled trials
  • Research Integrity
  • Systematic reviews
  • Trustworthiness

Fingerprint

Dive into the research topics of 'Assessing the feasibility and impact of clinical trial trustworthiness checks via an application to Cochrane Reviews: Stage 2 of the INSPECT-SR project'. Together they form a unique fingerprint.

Cite this